Abstract: There is provided herein a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, X1, X2, Y1 to Y4, Z1 to Z3 and n have meanings provided in the description.
Type:
Grant
Filed:
March 1, 2019
Date of Patent:
April 30, 2024
Assignee:
THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING
Inventors:
Armando Cázares-Körner, Thomas Helleday, Torkild Visnes, Olov Wallner, Tobias Koolmeister
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of cancers, inflammation, autoimmune diseases and graft-versus host diseases (e.g. in transplantation patients). A pharmaceutical composition comprising the compound or its salt and a method for preparing the compound.
Type:
Grant
Filed:
April 17, 2019
Date of Patent:
November 22, 2022
Assignee:
THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING
Inventors:
Christoffer Bengtsson, Sanjay Borhade, Martin Haraldsson, Thomas Helleday, Martin Henriksson, Evert Homan, Cynthia Paulin, Lars Sandberg, Martin Scobie, Pål Stenmark, Karl Vallin